Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › NY › Wellsville › NPI 1720030703
Hospital

The Memorial Hospital of William F. and Gertrude F. Jones, INC.

The Memorial Hospital of William F. and Gertrude F. Jones, INC. was paid $15.79M by Medicaid between Jan 2018 and Dec 2024, across 253 billing codes. Its largest line is G0463, Hospital outpatient clinic visit for assessment and management of a patient — 14% of everything it billed.

33Billing provider infoTHE MEMORIAL HOSPITAL OF WILLIAM F. AND GERTRUDE F. JONES, INC.
WELLSVILLE, NY 14895
33aNPI1720030703assigned 05/17/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$15.79M
24GClaims347,357
24DCodes billed253
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in New York

Rank by total paid#69 of 231
Median peer was paid$561K
This provider vs. median28×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$200K$400K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
20184,933$200K
201926,004$959K
202054,595$2.24M
202165,995$2.94M
202262,402$3.41M
202370,525$3.10M
2024incomplete62,903$2.93M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
G0463 Hospital outpatient clinic visit for assessment and management of a patient 14% 20,853 17,524 $2.25M
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 12% 31,232 27,269 $1.94M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 11% 11,721 11,127 $1.76M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 9.4% 8,422 8,046 $1.49M
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 4.9% 9,509 9,038 $768K
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 4.3% 3,961 3,820 $686K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 3.4% 7,530 7,147 $530K
99282 Emergency department visit for the evaluation and management, low to moderate severity 2.7% 2,026 1,974 $432K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 2.6% 6,423 5,534 $408K
36415 Collection of venous blood by venipuncture 2.2% 11,944 9,731 $346K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 1.9% 3,495 3,076 $295K
80053 Comprehensive metabolic panel 1.8% 17,199 14,349 $281K
241 more codes
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 1.7% 4,659 $274K
74177 Computed tomography, abdomen and pelvis; with contrast material 1.7% 1,381 $274K
96361 Intravenous infusion, hydration; each additional hour 1.2% 776 $195K
87631 1.2% 1,701 $193K
70450 Computed tomography, head or brain; without contrast material 1.2% 813 $192K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete 1.2% 880 $182K
81025 1.1% 3,396 $171K
59025 Fetal non-stress test 1.1% 1,168 $169K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 1.0% 1,191 $163K
G0378 Hospital observation service, per hour <1% 419 $151K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) <1% 1,747 $133K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) <1% 1,420 $112K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up <1% 1,704 $101K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) <1% 1,347 $95K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 2,600 $84K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 2,089 $76K
97161 <1% 919 $75K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 2,520 $73K
99395 Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years <1% 765 $73K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 3,356 $72K
80048 Basic metabolic panel (calcium, ionized) <1% 3,031 $59K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 291 $57K
99396 Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years <1% 529 $52K
84443 Thyroid stimulating hormone (TSH) <1% 6,619 $50K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 317 $49K
99173 <1% 969 $48K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 2,158 $47K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer <1% 1,424 $47K
85610 <1% 3,234 $46K
G0145 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision <1% 1,403 $39K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) <1% 420 $38K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 1,429 $38K
83036 Hemoglobin; glycosylated (A1C) <1% 4,294 $37K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 1,651 $37K
76801 <1% 473 $36K
80061 Lipid panel <1% 5,414 $36K
93010 Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only <1% 4,528 $36K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 188 $35K
90715 <1% 1,016 $33K
90686 <1% 1,243 $32K
71046 Radiologic examination, chest; 2 views <1% 3,823 $31K
86850 <1% 835 $31K
85027 <1% 6,822 $28K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 2,086 $24K
99215 Doctor's office visit, returning patient (complex) <1% 234 $23K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 13,356 $23K
71275 Computed tomographic angiography, chest, with contrast material <1% 102 $23K
83655 <1% 1,127 $20K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 2,007 $20K
90460 Immunization administration through 18 years of age via any route, first or only component <1% 1,241 $19K
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) <1% 13 $18K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 1,347 $18K
82607 <1% 1,501 $18K
84439 <1% 2,493 $18K
77067 Screening mammography, bilateral, including computer-aided detection <1% 243 $16K
82728 <1% 1,345 $15K
90648 <1% 775 $14K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel <1% 1,842 $14K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance <1% 202 $14K
90670 <1% 797 $14K
99203 Doctor's office visit, new patient (routine) <1% 187 $13K
87086 Culture, bacterial; quantitative colony count, urine <1% 3,196 $13K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 374 $12K
90677 <1% 275 $11K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 3,912 $11K
76770 <1% 129 $11K
87632 <1% 168 $11K
76830 Ultrasound, transvaginal <1% 137 $11K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 73 $10K
0012A <1% 282 $10K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 3,199 $10K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 102 $10K
90661 <1% 251 $9K
86901 <1% 980 $9K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 4,758 $9K
86900 <1% 977 $9K
83540 <1% 1,333 $8K
82746 <1% 774 $8K
81001 <1% 4,486 $8K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 315 $8K
90680 <1% 502 $8K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 488 $7K
90723 <1% 472 $7K
81002 <1% 2,520 $7K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 116 $6K
0011A <1% 285 $6K
86803 <1% 730 $6K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 968 $6K
92551 <1% 1,267 $6K
85380 <1% 581 $6K
99385 <1% 49 $6K
87081 <1% 3,153 $5K
83735 <1% 2,664 $5K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 1,236 $5K
84702 <1% 724 $5K
90633 <1% 318 $5K
99441 <1% 268 $5K
76811 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed <1% 53 $5K
73630 <1% 341 $5K
73030 <1% 414 $5K
81003 <1% 2,845 $5K
73562 <1% 215 $4K
73610 <1% 431 $4K
83880 <1% 180 $4K
84466 <1% 436 $4K
87480 <1% 735 $4K
87150 <1% 122 $4K
87660 <1% 757 $4K
99442 <1% 113 $4K
82570 <1% 1,062 $4K
87510 <1% 735 $4K
90707 <1% 216 $4K
99406 <1% 312 $4K
86780 <1% 348 $4K
71045 Radiologic examination, chest; single view <1% 1,321 $4K
87340 <1% 403 $4K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 158 $4K
73110 <1% 253 $3K
73130 <1% 315 $3K
96375 Therapeutic injection; each additional sequential IV push <1% 2,810 $3K
82043 <1% 703 $3K
90716 <1% 170 $3K
87186 <1% 845 $3K
93017 <1% 38 $3K
86140 <1% 1,868 $3K
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 242 $3K
90734 <1% 144 $3K
90688 <1% 93 $3K
92567 <1% 136 $2K
73564 <1% 191 $2K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 14 $2K
84153 <1% 113 $2K
77063 Screening digital breast tomosynthesis, bilateral <1% 148 $2K
80076 <1% 225 $2K
90698 <1% 105 $2K
0031A <1% 48 $2K
94010 <1% 159 $2K
72100 <1% 79 $2K
99223 Prolong inpt eval add15 m <1% 13 $2K
83550 <1% 384 $2K
0013A <1% 41 $2K
99238 Hospital discharge day management, 30 minutes or less <1% 41 $2K
83690 <1% 2,245 $2K
86618 <1% 139 $1K
0002A <1% 37 $1K
71250 <1% 12 $1K
71271 <1% 37 $1K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 38 $1K
86762 <1% 95 $1K
84484 <1% 2,797 $1K
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward <1% 54 $1K
80306 <1% 237 $1K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B <1% 45 $1K
85730 <1% 739 $1K
74018 <1% 139 $1K
0001A <1% 48 $1K
99222 Initial hospital care, per day, moderate complexity <1% 14 $994.35
90685 <1% 54 $974.74
80305 <1% 651 $968.08
85007 <1% 417 $940.47
90700 <1% 51 $922.88
G0103 Prostate cancer screening; prostate specific antigen test (psa) <1% 114 $896.85
85652 <1% 516 $896.53
87420 <1% 348 $805.79
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 69 $803.56
96127 <1% 215 $766.91
87400 <1% 556 $763.68
90651 <1% 31 $742.01
87430 <1% 616 $731.99
87158 <1% 1,218 $721.65
94727 <1% 27 $682.53
72125 Computed tomography, cervical spine; without contrast material <1% 15 $643.69
82150 <1% 571 $642.03
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme <1% 190 $633.84
90472 Immunization administration, each additional vaccine (list separately) <1% 1,132 $615.96
76536 <1% 25 $598.34
93971 <1% 28 $568.22
72110 <1% 32 $554.04
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 13 $548.94
87070 <1% 164 $523.39
90744 <1% 26 $471.26
Q9956 Injection, octafluoropropane microspheres, per ml <1% 17 $458.29
90656 <1% 18 $451.80
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 905 $425.74
84703 <1% 841 $357.68
84436 <1% 96 $353.40
84100 <1% 214 $351.48
86706 <1% 39 $299.52
85018 <1% 230 $290.41
94729 <1% 12 $280.60
90710 <1% 12 $279.98
Q0091 Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory <1% 12 $276.70
86038 <1% 53 $272.24
82950 <1% 77 $269.59
90713 <1% 13 $232.05
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 3,006 $227.80
J7120 Ringers lactate infusion, up to 1000 cc <1% 1,080 $196.21
83615 <1% 56 $192.71
86704 <1% 24 $175.66
73502 <1% 25 $165.26
87040 <1% 565 $149.98
83605 <1% 806 $91.10
74019 <1% 28 $70.56
87205 <1% 56 $60.78
84480 <1% 12 $59.34
82247 <1% 31 $57.21
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 2,677 $40.91
84479 <1% 14 $37.95
84550 <1% 16 $35.21
90473 <1% 253 $34.28
84145 <1% 157 $33.40
82550 <1% 28 $31.50
82565 <1% 13 $30.18
82248 <1% 14 $20.08
82040 <1% 13 $19.96
J1170 Injection, hydromorphone, up to 4 mg <1% 633 $13.29
80320 <1% 55 $10.00
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 1,134 $5.81
J2704 Injection, propofol, 10 mg <1% 828 $5.58
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 181 $5.46
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 43 $2.00
J3010 Injection, fentanyl citrate, 0.1 mg <1% 911 $2.00
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 43 $1.13
J0690 Injection, cefazolin sodium, 500 mg <1% 238 $0.62
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg <1% 83 $0.25
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg 0% 32 $0.00
99080 0% 2,337 $0.00
J1650 Injection, enoxaparin sodium, 10 mg 0% 52 $0.00
90461 0% 267 $0.00
J2270 Injection, morphine sulfate, up to 10 mg 0% 80 $0.00
80179 0% 13 $0.00
80143 0% 14 $0.00
J1596 Injection, glycopyrrolate, 0.1 mg 0% 12 $0.00
96160 0% 14 $0.00
3078F 0% 12 $0.00
96376 0% 369 $0.00
J2765 Injection, metoclopramide hcl, up to 10 mg 0% 64 $0.00
3079F 0% 25 $0.00
J2003 Injection, lidocaine hydrochloride, 1 mg 0% 45 $0.00
3074F 0% 79 $0.00
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg 0% 13 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialBENEDICT, EVA (C.E.O)